Vaccination coverage among students from a German health care college

Mäding, Carolin; Jacob, Christophe; Münch, Carola; Lindeman, Katharina von; Klewer, Jörg; Kügler, Joachim

doi:10.1016/j.ajic.2014.10.019

Cited by 9 publications

(8 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, differences at local level such as speci c campaigns may explain the variation, which has also been described by Haussig et al (24). Moreover, in this study self-reported vaccination status among PWID was only reported to be correct in 45% of participants, so VC might be overestimated in the study of Mone et al included in this review (62). In contrast to the data from Germany, the UK reported a VC of 77% from a voluntary unlinked-anonymous monitoring (UAM) among PWID in 2015-2016 (88).…”

Section: Discussionmentioning

confidence: 80%

“…In four studies data was collected among PWID. The not speci ed VC was between 10.5% and 52.5% in drug consumption facilities and in consumption places on the street (24,47,62), and between 19.0% and 49.0% in opioid substitution treatment centres (62,63).…”

Section: Hepatitis B Vaccination Coverage By Population Groupmentioning

confidence: 96%

“…In seven studies, HBV VC was investigated in different study populations, either as a single entity or as a sub-population (e.g. HIV-positive MSM) (18,19,28,37,49,60,62). Where applicable, these studies were therefore allocated to more than one population group below (28,37,49).…”

Section: Hepatitis B Vaccination Coverage By Population Groupmentioning

confidence: 99%

See 2 more Smart Citations

Hepatitis B Vaccination Coverage in Germany: Systematic Review

Steffen

Sperle

Harder

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: Despite being considered as a low prevalence country for hepatitis B (HBV), some populations in Germany are at higher risk of infection. In the context of the World Health Organization’s (WHO) viral hepatitis elimination goals a valid epidemiological data base is needed to plan and monitor the national response. Prevention strategies include general and targeted HBV vaccination programmes. Objective: The aim of this work was to estimate the HBV vaccination coverage (VC) in the general population (GP) and different population groups in Germany from available evidence and to identify current evidence gaps for future research.Methods: We conducted a systematic review on HBV VC in the general population and populations at high risk of HBV exposure or severe infection in Germany. We included eligible publications (01/01/2017 to 06/06/2020) from databases Embase, Pubmed and Livivo, from a previous scoping review (including data published 01/01/2005-17/03/2017), from the national surveillance system and screened the reference lists of all publications at full text level. Risk of bias was assessed using the Hoy et al tool. Results: We included 68 publications of 67 studies and assigned them to the respective population groups. Twenty-one studies contained data among children/adolescents and three among adults from the GP (VC 65.8% - 90.5% and 22.9% - 52.1%, respectively), one among travellers to HBV endemic countries (VC 89%), 13 among immunocompromised populations (VC 11.5% - 89%), 16 among populations with occupational risk and 16 with non-occupational risk of HBV exposure (VC 63.6% - 96.5% and 4.4% - 52%, respectively). Conclusion: Comprehensive evidence at low risk of bias was identified for children/adolescents. owever, 25 years after including HBV in the national immunisation schedule, VC in Germany is still below the 95%-goal defined by WHO. For people at occupational risk of HBV exposure, VC was mostly reported to be over the WHO goal of 80%, but quality of evidence was heterogenous and should be improved. For people at non-occupational risk of HBV exposure, evidence was sparse and of low quality. The low VC highlights the need for future research to plan vaccination programmes targeting these populations.

show abstract

Section: Discussionmentioning

confidence: 80%

Section: Hepatitis B Vaccination Coverage By Population Groupmentioning

confidence: 96%

See 1 more Smart Citation

Hepatitis B Vaccination Coverage in Germany: Systematic Review

Steffen

Sperle

Harder

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…For the remaining 32 publications (31 studies including the 14 where VC was determined by serology), the reported VC was assessed as “not specified”. For 12 studies VC of current protection was calculated [ 34 , 35 , 52 , 56 , 59 , 63 , 78 – 83 ].…”

Section: Resultsmentioning

confidence: 99%

Hepatitis B vaccination coverage in Germany: systematic review

et al. 2021

View full text Add to dashboard Cite

Background Despite being considered as a low prevalence country for hepatitis B (HBV), some populations in Germany are at higher risk of infection. In the context of the World Health Organization’s (WHO) viral hepatitis elimination goals, a valid epidemiological data base is needed to plan and monitor the national response. Prevention strategies include general and targeted HBV vaccination programmes. Objective The aim of this work was to estimate the HBV vaccination coverage (VC) in the general population (GP) and different population groups in Germany from available evidence and to identify current evidence gaps for future research. Methods We conducted a systematic review on HBV VC in the general population and populations at high risk of HBV exposure or severe infection in Germany. We included eligible publications (01/01/2017 to 06/06/2020) from databases Embase, Pubmed and Livivo, from a previous scoping review (including data published 01/01/2005–17/03/2017), from the national surveillance system and screened the reference lists of all publications at full text level. Risk of bias was assessed using the Hoy et al. tool. Results We included 68 publications of 67 studies and assigned them to one or more suitable population groups. Twenty-one studies contained data among children/adolescents and three among adults from the GP (VC 65.8–90.5% and 22.9–52.1%, respectively), one among travelers (VC 89.0%), 13 among immunocompromised populations (VC 7.8–89.0%), 16 among populations with occupational risk and 16 with non-occupational risk of HBV exposure (VC 63.6–96.5% and 4.4–84.5%, respectively). Conclusion Comprehensive evidence at low risk of bias was identified for children/adolescents. However, 25 years after including HBV in the national immunisation schedule, VC in Germany is still below the 95%-goal defined by WHO. For people at occupational risk of HBV exposure, VC was mostly reported to be over the WHO goal of 80%, but quality of evidence was heterogenous and should be improved. For people at non-occupational risk of HBV exposure, evidence was sparse and of low quality. The low VC highlights the need for future research to plan vaccination programmes targeting these populations.

show abstract

“…2262 Germans studied medicine/health science in Hungary in 2015/2016 [16, 17]), and encounters of people from different countries with different vaccination regulations, the risk for infectious diseases increases. Nevertheless, previous studies from Germany, France and Switzerland have demonstrated insufficient pertussis vaccination numbers of 17.1 to 72.7% in nursing and medical students [18–23].…”

Section: Introductionmentioning

confidence: 99%

Pertussis vaccination status and vaccine acceptance among medical students: multicenter study in Germany and Hungary

et al. 2019

Self Cite

View full text Add to dashboard Cite

BackgroundMedical students are at risk of contracting and transmitting infectious diseases such as pertussis. Complete vaccination status is important to protect own, patient and public health. Knowing own vaccination status is elementary for following current vaccination recommendations, including boosters. We aimed to assess pertussis vaccination status and vaccination acceptance among medical students of different nationalities.MethodsA cross-sectional multicenter health survey at German and Hungarian universities enclosed international medical students in the 1st, 3rd and 5th year of study. Self-reported data from 2655 students regarding pertussis vaccination status were analyzed. Subgroup analysis enclosed data of German (n = 1217), Hungarian (n = 960) and other nationality (n = 478) students (“other”).ResultsMore Hungarians reported basic immunization (39.0% vs 15.8% Germans vs 24.3% others, p ≤ 0.05). Booster vaccination was reported more by Germans (60.5% vs 43.6% Hungarians vs 36.0% others, p ≤ 0.05). Germans were more likely to report being unvaccinated (3.7% vs 0.9% Hungarians, p ≤ 0.05). More medical students of other nationalities were unaware of their pertussis vaccination status (37.4% vs 20.0% Germans/ 16.5% Hungarians, p ≤ 0.05). 75.2% (n = 1931) rated pertussis vaccinations as absolutely necessary (86.2% Hungarians vs 69.8% Germans/ 66.1% others, p ≤ 0.05).ConclusionsPositive attitudes towards vaccinations were reported but a large group reported insufficient vaccination status and being not aware of their status, especially among international students. Hungarians possibly have a better vaccination status than reported, based on mandatory vaccinations in childhood. The low awareness of vaccination status has implications for future booster vaccinations. All students should be informed about current recommendations and receive vaccination offers in frames of low-threshold medical services.

show abstract

Vaccination coverage among students from a German health care college

Cited by 9 publications

References 7 publications

Hepatitis B Vaccination Coverage in Germany: Systematic Review

Hepatitis B Vaccination Coverage in Germany: Systematic Review

Hepatitis B vaccination coverage in Germany: systematic review

Pertussis vaccination status and vaccine acceptance among medical students: multicenter study in Germany and Hungary

Contact Info

Product

Resources

About